Independent GLP-1 research, comparisons and global market intelligence Explore the platform →
SEMAGLUTIDESemaglutide is an active ingredient used across multiple products. Brand, formulation, approved use and jurisdiction should be checked separately.

SEMAGLUTIDE

Semaglutide: Uses, Brands, Evidence and Safety

Semaglutide sits behind several well-known medicines, but the active ingredient is only part of the picture. Product name, formulation, approved indication, evidence base and jurisdiction all matter.

Video explainer

How Semaglutide Fits Into GLP-1 Therapy

Research analysis

Semaglutide: Uses, Brands, Evidence and Safety

Semaglutide is a GLP-1 receptor agonist used in multiple prescription products. Products sharing semaglutide can differ in formulation, approved use, labeling and jurisdiction. EMA: Wegovy.

What semaglutide is

Semaglutide is the molecule. Wegovy, Ozempic and other semaglutide-containing products are specific medicines built around that molecule. Evidence from one product or indication should not automatically be transferred to another.

Wegovy and weight management

EMA currently lists Wegovy for weight management in specified populations. EMA.

Oral semaglutide changes the formulation landscape

In May 2026, EMA's CHMP recommended extending Wegovy to include a daily oral tablet as an alternative formulation to weekly injections for adult weight management. EMA.

Regulation is jurisdiction-specific

A product may be approved for one indication, population or formulation in one jurisdiction and treated differently elsewhere.

Safety and sourcing

WHO's July 2026 safety statement emphasized professional supervision and warned about self-medication and products from unverified sources. WHO.

Broader research resources

For separate consumer-health and performance-support research, see evidence-led men's health and performance research and men's performance product research. These are not semaglutide evidence sources.

Sources and references

See also the research methodology, corrections policy, medical disclaimer and affiliate disclosure.

Frequently asked questions

Questions about this topic

What is semaglutide?

A GLP-1 receptor agonist used as the active ingredient in several prescription medicines.

Are Ozempic and Wegovy the same?

They contain semaglutide but are distinct products with their own indications and labeling.

Is oral semaglutide available for weight management?

EMA added an oral Wegovy regulatory pathway in 2026; status remains jurisdiction-specific.

Is semaglutide a brand name?

No. Semaglutide is the active ingredient.

About the author

Research direction by Dr. Rahul Dev

Dr. Rahul Dev is a data scientist, patent attorney, life-sciences researcher and global business strategist with more than 20 years of professional experience. He founded GLP1Scientist to organize complex GLP-1 evidence, regulatory information, market data, patent intelligence and commercial developments into a connected global research platform.

Dr. Rahul Dev is not a physician. GLP1Scientist does not provide diagnosis, prescribing, medical care or individualized treatment recommendations.